Want to join the conversation?
$AXP's Discount revenue remained relatively flat in 2015 compared to 2014. This is driven by 2% growth in billed business, offset by fall in average discount rate, faster growth in GNS billings than in billings, rises in contra-discount revenues, such as cash rebate rewards and higher payments from cobrand partnership agreements.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.